Dehydroepiandrosterone sulfate and cognition in midlife, post-menopausal women

Neurobiol Aging. 2014 Jul;35(7):1654-5. doi: 10.1016/j.neurobiolaging.2014.01.140. Epub 2014 Jan 31.

Abstract

The association between serum dehydroepiandrosterone sulfate (DHEAS) and cognition was assessed in 218 healthy, midlife, post-menopausal women, aged 55-65 years. In cross-sectional analyses, DHEAS level was not significantly associated with a standardized score of global cognition or with individual test scores from a comprehensive neuropsychological battery (all p-values >0.05). In longitudinal analyses of 176 women, DHEAS level was unassociated with cognition 2 years later or with 2-year change in cognition. These findings fail to support the view that DHEAS is substantially related to cognitive function in midlife, post-menopausal women.

Keywords: Cognition; Dehydroepiandrosterone sulfate; Menopause; Midlife; Women.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cognition*
  • Cross-Sectional Studies
  • Dehydroepiandrosterone / blood*
  • Female
  • Humans
  • Longitudinal Studies
  • Middle Aged
  • Neuropsychological Tests
  • Postmenopause / blood*
  • Postmenopause / psychology*
  • Time Factors

Substances

  • Dehydroepiandrosterone